Eileen Doyle, PharmD is a drug development scientist who integrates clinical development, clinical pharmacology and pharmacometrics to support program strategy and regulatory filings. She is currently the Director of Clinical Pharmacology Modeling and Simulation for Infectious Diseases at GlaxoSmithKline and formerly held senior positions in clinical pharmacology and pharmacometrics/pharmacokinetcs at Certara and Sanofi.